147 related articles for article (PubMed ID: 31322833)
21. Echocardiographic findings in patients with sickle cell disease.
Naoman SG; Nouraie M; Castro OL; Nwokolo C; Fadojutimi-Akinsiku M; Diaz S; Willie-Carnegie G; Andrews N; Gordeuk VR
Ann Hematol; 2010 Jan; 89(1):61-6. PubMed ID: 19488751
[TBL] [Abstract][Full Text] [Related]
22. A prospective appraisal of pulmonary hypertension in children with sickle cell disease.
Sedrak A; Rao SP; Miller ST; Hekmat V; Rao M
J Pediatr Hematol Oncol; 2009 Feb; 31(2):97-100. PubMed ID: 19194191
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary hypertension in children and adolescents with sickle cell disease.
Onyekwere OC; Campbell A; Teshome M; Onyeagoro S; Sylvan C; Akintilo A; Hutchinson S; Ensing G; Gaskin P; Kato G; Rana S; Kwagyan J; Gordeuk V; Williams J; Castro O
Pediatr Cardiol; 2008 Mar; 29(2):309-12. PubMed ID: 17680298
[TBL] [Abstract][Full Text] [Related]
24. The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.
Musa BM; Galadanci NA; Coker M; Bussell S; Aliyu MH
Ann Hematol; 2016 Oct; 95(11):1757-64. PubMed ID: 27181705
[TBL] [Abstract][Full Text] [Related]
25. A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease.
Desai AA; Zhou T; Ahmad H; Zhang W; Mu W; Trevino S; Wade MS; Raghavachari N; Kato GJ; Peters-Lawrence MH; Thiruvoipati T; Turner K; Artz N; Huang Y; Patel AR; Yuan JX; Gordeuk VR; Lang RM; Garcia JG; Machado RF
Am J Respir Crit Care Med; 2012 Aug; 186(4):359-68. PubMed ID: 22679008
[TBL] [Abstract][Full Text] [Related]
26. Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease.
Dham N; Ensing G; Minniti C; Campbell A; Arteta M; Rana S; Darbari D; Nouraie M; Onyekwere O; Lasota M; Kato GJ; Gladwin MT; Castro O; Gordeuk V; Sable C
Am J Cardiol; 2009 Sep; 104(5):713-20. PubMed ID: 19699350
[TBL] [Abstract][Full Text] [Related]
27. Lower than expected elevated tricuspid regurgitant jet velocity in adults with sickle cell disease in Nigeria.
Musa BM; Odoh CN; Galadanci NA; Saidu H; Aliyu MH
Int Health; 2018 Sep; 10(5):356-362. PubMed ID: 29438485
[TBL] [Abstract][Full Text] [Related]
28. Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy.
Singer ST; Kuypers F; Fineman J; Gildengorin G; Larkin S; Sweeters N; Rosenfeld H; Kurio G; Higa A; Jeng M; Huang J; Vichinsky EP
Ann Hematol; 2014 Jul; 93(7):1139-48. PubMed ID: 24577514
[TBL] [Abstract][Full Text] [Related]
29. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary hypertension in sickle cell disease.
Lee MT; Rosenzweig EB; Cairo MS
Clin Adv Hematol Oncol; 2007 Aug; 5(8):645-53, 585. PubMed ID: 17982405
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary hypertension in sickle cell disease children under 10 years of age.
Colombatti R; Maschietto N; Varotto E; Grison A; Grazzina N; Meneghello L; Teso S; Carli M; Milanesi O; Sainati L
Br J Haematol; 2010 Sep; 150(5):601-9. PubMed ID: 20553267
[TBL] [Abstract][Full Text] [Related]
32. Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease.
Niss O; Quinn CT; Lane A; Daily J; Khoury PR; Bakeer N; Kimball TR; Towbin JA; Malik P; Taylor MD
JACC Cardiovasc Imaging; 2016 Mar; 9(3):243-52. PubMed ID: 26897687
[TBL] [Abstract][Full Text] [Related]
33. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.
Machado RF; Barst RJ; Yovetich NA; Hassell KL; Kato GJ; Gordeuk VR; Gibbs JS; Little JA; Schraufnagel DE; Krishnamurti L; Girgis RE; Morris CR; Rosenzweig EB; Badesch DB; Lanzkron S; Onyekwere O; Castro OL; Sachdev V; Waclawiw MA; Woolson R; Goldsmith JC; Gladwin MT;
Blood; 2011 Jul; 118(4):855-64. PubMed ID: 21527519
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia.
Rai P; Joshi VM; Goldberg JF; Yates AM; Okhomina VI; Penkert R; Ataga KI; Kang G; Hankins JS
Blood Adv; 2021 Jan; 5(1):89-98. PubMed ID: 33570630
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary hypertension in Nigerian adults with sickle cell anemia.
Amadi VN; Balogun MO; Akinola NO; Adebayo RA; Akintomide AO
Vasc Health Risk Manag; 2017; 13():153-160. PubMed ID: 28507438
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study.
van Tuijn CFJ; Schimmel M; van Beers EJ; Nur E; Biemond BJ
Am J Hematol; 2017 Oct; 92(10):E584-E590. PubMed ID: 28699283
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.
Gladwin MT; Barst RJ; Gibbs JS; Hildesheim M; Sachdev V; Nouraie M; Hassell KL; Little JA; Schraufnagel DE; Krishnamurti L; Novelli E; Girgis RE; Morris CR; Berman Rosenzweig E; Badesch DB; Lanzkron S; Castro OL; Taylor JG; Goldsmith JC; Kato GJ; Gordeuk VR; Machado RF;
PLoS One; 2014; 9(7):e99489. PubMed ID: 24988120
[TBL] [Abstract][Full Text] [Related]
38. Tricuspid regurgitant jet velocity and myocardial tissue Doppler parameters predict mortality in a cohort of patients with sickle cell disease spanning from pediatric to adult age groups - revisiting this controversial concept after 16 years of additional evidence.
Shah P; Suriany S; Kato R; Bush AM; Chalacheva P; Veluswamy S; Denton CC; Russell K; Khaleel M; Forman HJ; Khoo MCK; Sposto R; Coates TD; Wood JC; Detterich J
Am J Hematol; 2021 Jan; 96(1):31-39. PubMed ID: 32944977
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary hypertension in well-transfused thalassemia major patients.
Meloni A; Detterich J; Pepe A; Harmatz P; Coates TD; Wood JC
Blood Cells Mol Dis; 2015 Feb; 54(2):189-94. PubMed ID: 25488617
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria.
Aliyu ZY; Gordeuk V; Sachdev V; Babadoko A; Mamman AI; Akpanpe P; Attah E; Suleiman Y; Aliyu N; Yusuf J; Mendelsohn L; Kato GJ; Gladwin MT
Am J Hematol; 2008 Jun; 83(6):485-90. PubMed ID: 18306362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
